AngioJet® rheolytic thrombectomy for acute superficial femoral artery stent or femoropopliteal by-pass thrombosis

Monaldi Archives for Chest Disease - Cardiac Series

Volumn 74, Issue 2, 2010, Pages 76-81

  Borgia, Francesco ^a   Di Serafino, Luigi ^a   Sannino, Anna ^a   Gargiulo, Giuseppe ^a   Schiattarella, Gabriele Giacomo ^a   De Laurentis, Mario ^a   Scudiero, Laura ^a   Perrino, Cinzia ^a   Piscione, Federico ^a   Esposito, Giovanni ^a   Chiariello, Massimo ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Acute limb ischemia; AngioJet ; Rheolytic thrombectomy; Stent thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; ATORVASTATIN; BISOPROLOL; CARDIOLIPIN ANTIBODY; CLOPIDOGREL; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M ANTIBODY; METHOTREXATE; NITINOL; POLITEF; VALSARTAN; HEPARIN; WARFARIN;

ACUTE SUPERFICIAL FEMORAL ARTERY STENT; AGED; ANGIOGRAPHY; ANTICOAGULATION; ARTERY THROMBOSIS; ARTICLE; AUTOIMMUNITY; BLOOD SAMPLING; CASE REPORT; CLINICAL EVALUATION; DOPPLER ECHOGRAPHY; FEMALE; FEMOROPOPLITEAL BY PASS THROMBOSIS; FOLLOW UP; FOOT PAIN; GASTROINTESTINAL HEMORRHAGE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; LIMB ISCHEMIA; LIMB SALVAGE; LOADING DRUG DOSE; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POLITEF IMPLANT; RECANALIZATION; RHEOLYTIC THROMBECTOMY; STENT THROMBOSIS; TOE GANGRENE; TREATMENT OUTCOME; WALKING DIFFICULTY; ACUTE LIMB ISCHEMIA; ACUTE SUPERFICIAL FEMORAL ARTERY STENT THROMBOSIS; BLOOD EXAMINATION; DISEASE CLASSIFICATION; ECHOGRAPHY; FEMOROPOPLITEAL BYPASS THROMBOSIS; FONTAINE STAGE; GUIDE WIRE; HYPERCHOLESTEROLEMIA; HYPERTENSION; ILIAC ARTERY OBSTRUCTION; LEG ISCHEMIA; NITINOL STENT; OCCLUSION BALLOON CATHETER; RHEUMATOID ARTHRITIS; SELF EXPANDING STENT; THROMBECTOMY CATHETER; THROMBOEMBOLISM; THROMBOSIS; TOE ULCER; ULCER; ANAMNESIS; FEMOROPOPLITEAL BYPASS; SUPERFICIAL FEMORAL ARTERY;

EID: 77957687572     PISSN: 11220643     EISSN: None     Source Type: Journal    
DOI: 10.4081/monaldi.2010.271     Document Type: Article

References (18)

1. Schillinger M, Sabeti S, Loewe C, et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 2006; 354 (18): 1879-88.
2. Schillinger M, Sabeti S, Dick P, et al. Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting. Circulation 2007; 115 (21): 2745-9. (Pubitemid 46842791)
3. Duda SH, Bosiers M, Lammer J, et al. Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II trial. J Vasc Interv Radiol 2005; 16 (3): 331-8. (Pubitemid 40354849)
4. Laird JR. Limitations of percutaneous transluminal angioplasty and stenting for the treatment of disease of the superficial femoral and popliteal arteries. J Endovasc Ther 2006; 13 Suppl 2: II30-40.
5. Ruef J, Hofmann M, Haase J. Initial clinical experience with the Protege EverFlex long self-expanding nitinol stent in the superficial femoral artery. J Interv Cardiol 2006; 19 (6): 544-6.
6. Bhatt DL, Flather MD, Hacke W, et al. Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial. J Am Coll Cardiol 2007; 49 (19): 1982-8.
7. Blinc A, Poredos P. Pharmacological prevention of atherothrombotic events in patients with peripheral arterial disease. Eur J Clin Invest 2007; 37 (3): 157-64. (Pubitemid 46310580)
8. Lumsden AB, Rice TW. Medical management of peripheral arterial disease: a therapeutic algorithm. J Endovasc Ther 2006; 13 Suppl 2: II19-29.
9. Kuntz RE, Baim DS, Cohen DJ, et al. A trial comparing rheolytic thrombectomy with intracoronary urokinase for coronary and vein graft thrombus (the Vein Graft AngioJet Study [VeGAS 2]). Am J Cardiol 2002; 89 (3): 326-30.
10. Margheri M, Falai M, Vittori G, et al. Safety and efficacy of the AngioJet in patients with acute myocardial infarction: results from the Florence Appraisal Study of Rheolytic Thrombectomy (FAST). J Invasive Cardiol 2006; 18 (10): 481-6.
11. Ali A, Cox D, Dib N, Brodie B, et al. Rheolytic thrombectomy with percutaneous coronary intervention for infarct size reduction in acute myocardial infarction: 30-day results from a multicenter randomized study. J Am Coll Cardiol 2006; 48 (2): 244-52.
12. Mannava K, Money SR. Current management of peripheral arterial occlusive disease: a review of pharmacologic agents and other interventions. Am J Cardiovasc Drugs 2007; 7(1): 59-66.
13. Ouriel K. Comparison of surgical and thrombolytic treatment of peripheral arterial disease. Rev Cardiovasc Med 2002; 3 Suppl 2: S7-16. (Pubitemid 36221606)
14. Ouriel K, Shortell CK, DeWeese JA, et al. A comparison of thrombolytic therapy with operative revascularization in the initial treatment of acute peripheral arterial ischemia. J Vasc Surg 1994; 19 (6): 1021-30.
15. Ouriel K, Veith FJ, Sasahara AA. Thrombolysis or peripheral arterial surgery: phase I results. TOPAS Investigators. J Vasc Surg 1996; 23 (1): 64-73; discussion 74-5.
16. Ouriel K. Endovascular techniques in the treatment of acute limb ischemia: thrombolytic agents, trials, and percutaneous mechanical thrombectomy techniques. Semin Vasc Surg 2003; 16 (4): 270-9.
17. Kasirajan K, Gray B, Beavers FP, et al. Rheolytic thrombectomy in the management of acute and subacute limb-threatening ischemia. J Vasc Interv Radiol 2001; 12 (4): 413-21.
18. Kasirajan K, Ramaiah VG, Diethrich EB. The Trellis Thrombectomy System in the treatment of acute limb ischemia. J Endovasc Ther 2003; 10 (2): 317-21.